FORSYTH DOUGLAS bought INBX
June 3, 2026 · Form 4 insider transaction
FORSYTH DOUGLAS bought 10,000 shares of Inhibrx Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 107 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$0.00
Total value
N/A
InsiderFORSYTH DOUGLAS
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 3, 2026
Filing dateSeptember 18, 2026
Shares owned after10,000
OwnershipDirect
10b5-1 planNo
AmendedYes
Footnotes
This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date.